Xin Lang Cai Jing·2025-09-05 07:38Company Overview - WuXi AppTec Co., Ltd. is a leading global pharmaceutical and biotechnology company, providing comprehensive services in drug discovery, development, and manufacturing [1] - The company was established on December 1, 2000, and went public on May 8, 2018 [1] - The main business segments include small molecule chemistry (78.37%), testing services (12.93%), biological services (6.02%), and other services (1.90%) [1] Stock Performance - On September 5, the stock price of WuXi AppTec increased by 5.09%, reaching 107.13 CNY per share, with a trading volume of 7.877 billion CNY and a turnover rate of 3.05% [1] - The total market capitalization of the company is approximately 316.195 billion CNY [1] Fund Holdings - The Shangyin Fengyi Mixed A Fund (011504) holds a position in WuXi AppTec, having reduced its holdings by 2,000 shares in the second quarter, now holding 10,000 shares, which represents 1.26% of the fund's net value [2] - The fund has achieved a floating profit of approximately 51,900 CNY from its investment in WuXi AppTec [2] Fund Manager Information - The fund manager of Shangyin Fengyi Mixed A is Gao Yong, who has been in the position for 8 years and 255 days [3] - The total asset size of the fund is 55.1468 million CNY, with a best return of 23.78% during Gao Yong's tenure [3]